1. Mollicellins S-U, three new depsidones from Chaetomium brasiliense SD-596 with anti-MRSA activities
- Author
-
Lumin Yu, Xin Yin, Xinzhu Wang, Zhipu Li, Peipei Zhao, Meng Yiwei, Jun Qi, Hong Wang, Guoliang Zhu, Bo Zhao, Xuekui Xia, Meng Yang, Lixin Zhang, and Hairong Liu
- Subjects
0301 basic medicine ,Pharmacology ,010405 organic chemistry ,Depsidone ,Stereochemistry ,030106 microbiology ,Anti mrsa ,medicine.disease_cause ,01 natural sciences ,0104 chemical sciences ,Chaetomium brasiliense ,03 medical and health sciences ,chemistry.chemical_compound ,chemistry ,Staphylococcus aureus ,Mic values ,Drug Discovery ,medicine ,Fermentation - Abstract
Fungi are important resources for drug development, as they have a diversity of genes, that can produce novel secondary metabolites with effective bioactivities. Here, five depsidone-based analogs were isolated from the rice media of Chaetomium brasiliense SD-596. Their structures were elucidated using NMR and mass spectrometry analysis. Five compounds, including three new depsidone analogs, mollicellin S (1), mollicellin T (2), and mollicellin U (3), and two known compounds, mollicellin D (4) and mollicellin H (5), exhibited significant inhibition against Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA), with MIC values ranging from 6.25 to 12.5 μg ml-1. Herein, we identified the predicted plausible biosynthetic cluster of the compounds and discussed the structure-activity relationship. Finally, we found that the introduction of aldehyde and methoxyl groups provide marked improvement for the inhibition against MRSA.
- Published
- 2021
- Full Text
- View/download PDF